Jiangsu Hengrui Pharmaceuticals Co.,Ltd
600276.SS
Ci-dessous : le cours en direct de Jiangsu Hengrui Pharmaceuticals Co.,Ltd (600276.SS), un graphique 1 an, 8 indicateurs (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume) et le mode de comparaison. Ajoutez à votre portefeuille, mettez en favori ou définissez des alertes de prix.
- Prev close
- $6.43
- Volume
- $9.61M
- Market cap
- $43.61B
- Currency
- USD (native CNY)
Financials
- 52w high
- ¥74.04
- 52w low
- ¥47.20
- 52w change
- -12.40%
- Day high
- ¥48.72
- Day low
- ¥47.37
- P/E (TTM)
- 39.05
- Forward P/E
- 27.6
- PEG
- 0.93
- Price / Book
- 5.03
- Beta (5Y)
- 0.17
- Enterprise value
- 272.96B
- EV / Revenue
- 8.38
- EV / EBITDA
- 28.88
- EPS (TTM)
- ¥1.22
- Forward EPS
- ¥1.73
- Dividend yield
- 0.43%
- Dividend rate
- ¥0.20
- Payout ratio
- 16.39%
- Revenue (TTM)
- 32.56B
- EBITDA
- 9.45B
- Free cash flow
- 6.31B
- Total cash
- 40.64B
- Total debt
- 67.47M
- Debt / Equity
- 0.11
- Current ratio
- 9.23
- Quick ratio
- 8.36
- Profit margin
- 24.93%
- Gross margin
- 86.27%
- Return on assets
- 8.80%
- Return on equity
- 14.54%
- Shares outstanding
- 6.38B
- Float
- 3.77B
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Analyst & Risk
- Beta (vs S&P 500)
- 0.17
- very stable
- 52-week change
- -12.40%
- Debt / Equity
- 0.11
- low leverage
- Current ratio
- 9.23
- Quick ratio
- 8.36
- ROE
- 14.54%
- ROA
- 8.80%
- PEG ratio
- 0.93
- potentially undervalued
- EV / Revenue
- 8.38
- EV / EBITDA
- 28.88
- Revenue growth
- 13.00%
- Earnings growth
- 13.30%
- EBITDA
- 9.45B
- Free cash flow
- 6.31B
- Total cash
- 40.64B
- Total debt
- 67.47M
- Insider holdings
- 46.26%
- Institutional
- 16.59%
Actualités récentes
- Uber reveals an unexpected problem behind the AI boomTheStreet7m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.9m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.11m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory13m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool13m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire14m ago
- Kupcho seizes slim lead in US Women's Open at RivieraAFP16m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily8m ago
Discussion en direct
Connexion to join the discussion.
- Aucun commentaire. Soyez le premier.